Roth Capital Starts Prosensa (RNA) at Neutral
Tweet
Share
E-mailGet Alerts RNA Hot Sheet
Price: $8.28 -1.66%
Rating Summary:
12 Buy, 11 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 11 | New: 35
Rating Summary:
12 Buy, 11 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 11 | New: 35
Join SI Premium – FREE
Roth Capital initiated coverage on Prosensa (NASDAQ: RNA) with a Neutral rating and a price target of $12.00.
For an analyst ratings summary and ratings history on Prosensa click here. For more ratings news on Prosensa click here.
Shares of Prosensa closed at $10.80 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Canaccord Starts First Tracks Biotherapeutics (TRAX) at Buy
- Goldman Sachs Resumes Enbridge Inc. (ENB:CN) (ENB) at Neutral
- BofA Securities Reinstates Mouwasat (4002:AB) at Underperform
Create E-mail Alert Related Categories
New CoverageRelated Entities
Roth CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
